AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GELION PLC

Declaration of Voting Results & Voting Rights Announcements Dec 31, 2025

7666_dva_2025-12-31_84c8fa8f-f543-41ab-a9c3-ae252c78f2b2.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0027N

Gelion PLC

31 December 2025

31 December 2025

Gelion PLC

(the "Company" or the "Group")

Total Voting Rights

In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that following the exercise of share options during the month of December 2025, the Company has 229,421,456 ordinary shares of 0.1 pence each in issue. The Company does not hold any shares in treasury and all of the ordinary shares have equal voting rights.

The figure of 229,421,456 ordinary shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

Enquiries:

Gelion plc

John Wood, CEO

Amit Gupta, CFO
via Alma
Strand Hanson Limited (Nominated and Financial Adviser)

Christopher Raggett / Rob Patrick / Harry Marshall
+44 (0) 20 7409 3494
Oberon Capital (Joint Broker)

Nick Lovering / Mike Seabrook / Adam Pollock
+44 (0) 20 3179 5300
Allenby Capital Limited (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)
+44 (0) 20 3328 5656
Alma Strategic Communications (Financial PR)

Justine James / Hannah Campbell / Rose Docherty
+44 (0) 20 3405 0205

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREAFANADSSFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.